PubMed
Cerebrolysin for acute ischemic stroke (review)
Chen N, Yang M, Guo J, et al. Cochrane Database Syst Rev. 2017
Compare
Cerebrolysin vs GLOW Blend
Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.
Last reviewed . By the PeptIQ team.
Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.
Cerebrolysin
6 community reports
Overall experience
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 100% · Mixed 0% · Unfavorable overall 0%
Most reported benefits
Benefits users selected when logging a favorable or mixed check-in.
Cognition
6
Self-reported dose per injection
Median bucket: 0–25 mcg · Most common: 0–25 mcg
Reports span 0–50 mcg
0–25
4
25–50
2
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Commonly stacked with
GLOW Blend
1281 community reports
Overall experience
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 45% · Mixed 38% · Unfavorable overall 17%
Most reported benefits
Benefits users selected when logging a favorable or mixed check-in.
Skin appearance
68
Appetite control
19
Energy
170
Mood
189
Focus
124
Most logged side effects
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Headache
164
GI discomfort
98
Dizziness
135
Fatigue
184
Nausea
123
Self-reported dose per injection
Median bucket: 200–400 mcg · Most common: 200–400 mcg
Reports span 50–1000 mcg
50–100
7
100–200
11
200–400
21
400–600
11
600–1000
7
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Commonly stacked with
Common discussion topics
timing45stacking28side effects11glow blend14
How repeat users are trending
Among repeat reporters, 55% said they felt similar to their last entry, 43% more positive, and 15% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 32 days · Based on 282 repeat reporters
Sources (5)
Published sources linked on the Cerebrolysin and GLOW Blend wiki pages.
- Wiki study page →Source
- Wiki study page →Source
PubMed
Cerebrolysin for acute ischaemic stroke
Ziganshina LE, Abakumova T, Nurkhametova D, et al. The Cochrane database of systematic reviews. 2023
- Wiki study page →Source
PubMed
Cerebrolysin for acute ischaemic stroke
Ziganshina LE, Abakumova T, Vernay L. The Cochrane database of systematic reviews. 2017
- Wiki study page →Source
PubMed
Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract
Sikiric P, Seiwerth S, Rucman R, et al. Curr Pharm Des. 2018
- Wiki study page →Source
Review Article
GHK-Cu may prevent oxidative stress in skin by regulating copper and modifying expression of numerous antioxidant genes
Pickart L, Margolina A. Cosmetics. 2018